Shalby Ltd.
| BSE: 540797 | Sector: Health care |
| NSE: SHALBY | ISIN Code: INE597J01018 |
| BSE 09:09 | 19 Oct | 166.90 |
0.65 (0.39%) |
OPEN
166.90 |
HIGH
166.90 |
LOW
166.90 |
| NSE 00:00 | 18 Oct | 166.15 |
-2.70 (-1.60%) |
OPEN
170.00 |
HIGH
171.35 |
LOW
165.10 |
| OPEN | 166.90 |
| PREVIOUS CLOSE | 166.25 |
| VOLUME | 75 |
| 52-Week high | 214.00 |
| 52-Week low | 86.45 |
| P/E | 23.61 |
| Mkt Cap.(Rs cr) | 1,803 |
| Buy Price | 166.00 |
| Buy Qty | 5.00 |
| Sell Price | 166.90 |
| Sell Qty | 117.00 |
Shalby Ltd. (SHALBY) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 725.00 | 6.75 | 0.94 | 3112.91 |
| Cipla | 905.00 | 1.20 | 0.13 | 2468.28 |
| Dr Reddy's Labs | 4919.00 | 45.15 | 0.93 | 2186.40 |
| Sun Pharma.Inds. | 840.00 | 4.80 | 0.57 | 2139.70 |
| Divi's Lab. | 5350.00 | 10.40 | 0.19 | 1954.72 |
| Alkem Lab | 3872.70 | 10.20 | 0.26 | 1685.08 |
| Glenmark Pharma. | 519.00 | -0.50 | -0.10 | 1649.45 |
| Cadila Health. | 533.65 | -0.90 | -0.17 | 1476.20 |
| Lupin | 940.00 | 3.15 | 0.34 | 1258.62 |
| Alembic Pharma | 810.00 | -1.40 | -0.17 | 1175.39 |
| Ipca Labs. | 2429.70 | 16.35 | 0.68 | 1140.77 |
| Gland Pharma | 3752.00 | 0.60 | 0.02 | 997.01 |
| Laurus Labs | 645.10 | -0.25 | -0.04 | 956.11 |
| Ajanta Pharma | 2180.05 | -31.10 | -1.41 | 675.64 |
| Wockhardt | 482.80 | 0.00 | 0.00 | 593.29 |
| Granules India | 326.95 | 1.80 | 0.55 | 552.78 |
| Sanofi India | 8215.00 | -31.55 | -0.38 | 477.60 |
| IOL Chemicals | 614.00 | 7.50 | 1.24 | 444.56 |
| Glenmark Life | 656.50 | -0.65 | -0.10 | 351.58 |
| ERIS Lifescience | 837.00 | 0.75 | 0.09 | 350.61 |
Quick Links for Shalby:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
